Scarica l'app Stockscreener
6.72
10.71%
0.65
Dopo l'orario di chiusura:
6.50
-0.22
-3.27%
Precedente Chiudi:
$6.07
Aprire:
$6.08
Volume 24 ore:
210.01K
Relative Volume:
3.35
Capitalizzazione di mercato:
$112.39M
Reddito:
-
Utile/perdita netta:
$-14.88M
Rapporto P/E:
-6.8571
EPS:
-0.98
Flusso di cassa netto:
$-10.29M
1 W Prestazione:
+12.75%
1M Prestazione:
+16.06%
6M Prestazione:
+13.90%
1 anno Prestazione:
-5.22%
Intervallo 1D:
$6.0692
$6.7726
Intervallo di 1 settimana:
$5.66
$6.7726
Portata 52W:
$4.65
$10.24
Coya Therapeutics Inc Stock (COYA) Company Profile
Nome
Coya Therapeutics Inc
Settore
Industria
Telefono
650.739.3939
Indirizzo
12645 MEMORIAL DR., SUITE F1 #305, HOUSTON
Confronta COYA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
COYA
Coya Therapeutics Inc
|
6.72 | 95.17M | 0 | -14.88M | -10.29M | -0.98 |
|
VRTX
Vertex Pharmaceuticals Inc
|
472.27 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.64 | 61.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.00 | 42.46B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.74 | 35.22B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
296.46 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Coya Therapeutics Inc Stock (COYA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-09 | Iniziato | Lake Street | Buy |
| 2024-12-04 | Iniziato | D. Boral Capital | Buy |
Coya Therapeutics Inc Borsa (COYA) Ultime notizie
Coya Therapeutics publishes new research study on progression of Parkinson’s - TipRanks
Coya Therapeutics, Inc. Announces Publication of Scientific Research Linking Inflammation and Oxidative Stress to the Progression of Parkinson's Disease - MarketScreener
New Research Reveals Critical Inflammation Pathway in Parkinson's Disease, Potential Treatment Breakthrough - Stock Titan
What analysts say about Coya Therapeutics Inc. stockAccelerated profit realization - Autocar Professional
What drives Coya Therapeutics Inc. stock priceTriple-digit return opportunities - Autocar Professional
Rh shares rise 1.14% premarket after Coya Therapeutics to participate in the BTIG Virtual Biotechnology Conference. - AInvest
Coya Therapeutics Inc. Stock Analysis and ForecastBreakout stock performance - jammulinksnews.com
Is Coya Therapeutics Inc. a good long term investmentFree Wealth Management Insights - jammulinksnews.com
Why Coya Therapeutics Inc. stock attracts strong analyst attentionMomentum Swing Watchlist - Newser
Coya Therapeutics shares rise 4.67% premarket after announcing participation in the BTIG Virtual Biotechnology Conference. - AInvest
Digi Power X Secures $15 Million in Direct Stock Offering - The Globe and Mail
Coya Therapeutics to Participate in BTIG Virtual Biotechnology Conference - AInvest
Coya Therapeutics to Participate in the BTIG Virtual Biotechnology Conference July 29 – 30, 2025 - Business Wire
(COYA) Investment Report - news.stocktradersdaily.com
What drives BENFW stock priceConsistent double returns - jammulinksnews.com
What makes Coya Therapeutics Inc. stock price move sharplyLow Risk Trade Timing Signals - Newser
How Coya Therapeutics Inc. stock performs during market volatilityFree Stock Selection with 300% Return - Newser
Coya Therapeutics (NASDAQ:COYA) Coverage Initiated at Lake Street Capital - Defense World
Coya Therapeutics initiated with a Buy at Lake Street - TipRanks
Coya Therapeutics stock initiated with Buy rating at Lake Street Capital - Investing.com UK
With CAR Ts and islets raising the bar in I&I, what’s the play for Tregs? - biocentury.com
Positive Outlook for Coya Therapeutics, Inc. Driven by IND Resubmission and Promising Trial Results - TipRanks
Coya Therapeutics (COYA) Receives Continued Buy Rating from Analyst | COYA Stock News - GuruFocus
Coya Therapeutics Inc Azioni (COYA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.32%
1.57%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):